At the annual meeting of the Industrial Biotechnology Innovation Center (IBioIC), the writer and broadcaster Vivienne Parry would say that scientists can sometimes struggle to explain the urgency of the efforts to save the planet.
At the next month’s meeting, she will be one of the keynote speakers, where over 450 delegates and many businesses will deliver their insightful ideas to a global public.
Parry is a trained scientist and a member of the British Research and Innovation Committee, he’s the Head of Engagement for Genomics England. Formerly she has been part of the BBC program Tomorrow’s World.
Biotechnology is the research of the production or processing of materials, chemicals, and energies using plant and waste resources and offers green and sustainable alternatives for fossil fuels in all areas, from energy to medicine and food packaging.
To date, IBioIC has overseen IB’s doubling to over £ 350 million in Scotland and funded over 130 businesses, 50 research projects, and 18 Scottish universities and institutions.
At IBioIC, international experts will share their knowledge, challenges, opportunities and best practices and will again highlight the potential of Scotland to drive the bio-based economy.
Nevertheless, if they are to build on their inventions, a change of attitude from great science to effective output is required. The transition to production generally occurs with considerable capital investments, which ensure that prospective supporters can demonstrate reliable processes.
Bustard also listed several of Scotland’s biotech success stories.
The role played by bio-based industries in combating the effects of climate change and building a circular economy to achieve the government’s net carbon zero by 2045 is increasingly recognized and sponsored.
Companies such as ScotBio, CelluComp, and Celtic Renewables are fantastic examples of winners, all of which are using science for producing products. These are excellent examples. They create employees of manufacturers interested in innovation.